Urokinase receptor cleavage: A crucial step in 14 fibroblast-to-myofibroblast differentiation

被引:77
作者
Bernstein, Audrey M. [1 ]
Twining, Sally S.
Warejcka, Debra J.
Tall, Edward
Masur, Sandra K.
机构
[1] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA
[3] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
D O I
10.1091/mbc.E06-10-0912
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fibroblasts migrate into and repopulate connective tissue wounds. At the wound edge, fibroblasts differentiate into myofibroblasts, and they promote wound closure. Regulated fibroblast-to-myofibroblast differentiation is critical for regenerative healing. Previous studies have focused on the role in fibroblasts of urokinase plasmingen activator/urokinase plasmingen activator receptor (uPA/uPAR), an extracellular protease system that promotes matrix remodeling, growth factor activation, and cell migration. Whereas fibroblasts have substantial uPA activity and uPAR expression, we discovered that cultured myofibroblasts eventually lost cell surface uPA/uPAR. This led us to investigate the relevance of uPA/uPAR activity to myofibroblast differentiation. We found that fibroblasts expressed increased amounts of full-length cell surface uPAR (D1D2D3) compared with myofibroblasts, which had reduced expression of D1D2D3 but increased expression of the truncated form of uPAR (D2D3) on their cell surface. Retaining full-length uPAR was found to be essential for regulating myofibroblast differentiation, because 1) protease inhibitors that prevented uPAR cleavage also prevented myofibroblast differentiation, and 2) overexpression of cDNA for a noncleavable form of uPAR inhibited myofibroblast differentiation. These data support a novel hypothesis that maintaining full-length uPAR on the cell surface regulates the fibroblast to myofibroblast transition and that down-regulation of uPAR is necessary for myofibroblast differentiation.
引用
收藏
页码:2716 / 2727
页数:12
相关论文
共 59 条
[51]   ALPHA-1-ANTICHYMOTRYPSIN IS PRESENT IN AND SYNTHESIZED BY THE CORNEA [J].
TWINING, SS ;
FUKUCHI, T ;
YUE, BYJT ;
WILSON, PM ;
ZHOU, XY .
CURRENT EYE RESEARCH, 1994, 13 (06) :433-439
[52]  
Twining SS, 1996, INVEST OPHTH VIS SCI, V37, P511
[53]   Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin [J].
Waltz, DA ;
Natkin, LR ;
Fujita, RM ;
Wei, Y ;
Chapman, HA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (01) :58-67
[54]  
Warejcka D, 2005, MOL VIS, V11, P859
[55]   The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro [J].
Webb, DJ ;
Nguyen, DHD ;
Sankovic, M ;
Gonias, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7412-7420
[56]   Regulation of integrin function by the urokinase receptor [J].
Wei, Y ;
Lukashev, M ;
Simon, DI ;
Bodary, SC ;
Rosenberg, S ;
Doyle, MV ;
Chapman, HA .
SCIENCE, 1996, 273 (5281) :1551-1555
[58]  
Whitelock RB, 1997, INVEST OPHTH VIS SCI, V38, P529
[59]   DIRECT FLUORESCENT ASSAY OF UROKINASE AND PLASMINOGEN ACTIVATORS OF NORMAL AND MALIGNANT CELLS - KINETICS AND INHIBITOR PROFILES [J].
ZIMMERMAN, M ;
QUIGLEY, JP ;
ASHE, B ;
DORN, C ;
GOLDFARB, R ;
TROLL, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (02) :750-753